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A B S T R A C T
This study describe the infection fatality rate (IFR) by COVID-19 by age groups in one department of
Colombia. It used results from a serological survey to stablish a closer estimation of the true proportion of
infected people. It found an overall IFR of 0.24% quite lower than the overall CFR (5.6%). We conclude that
CFR severely overestimate the lethality of COVID-19 in developing areas.
© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
The infection fatality rate (IFR) is a critical epidemiological
parameter that allows assessment of the dynamics and virulence of
any infectious agent and the quality of health services (Levin et al.,
2020). There is still uncertainty about the true IFR of COVID-19
because detecting all infections and cases depends on the quality of
surveillance and the number of tests available. Attempting to
estimate IFR in developing countries is incredibly challenging
because they have weaker surveillance systems coupled with a
deficit of laboratories able to carry out molecular tests across the
entire territory. There have been attempts to estimate IFR using
serological estimates, but there are few serological studies from
developing countries. In systematic reviews conducted by
Ioannidis and Levin et al., only 6 developing countries had IFR
estimates (Levin et al., 2020; Ioannidis, 2021).
By March 5, 2021, Colombia has been hit by 2 waves of COVID-19,
reporting2.2 millioncasesand 60 300 deaths (casefatality rate, CFR =
2.6%) (Instituto Nacional de Salud (INS), 2021). However, the actual
number of infected people is unknown because of geographical
differences in the surveillance system performance and laboratory
capacities. Thus, Colombia lacks accurate estimates on IFR (Hurtado-
Ortiz et al., 2020). So far, only 3 Latin American countries—Argentina,
Brazil and Chile—have informed IFR from serological surveys
(Ioannidis, 2021). In this short report, we attempt to fill that gap
by estimating IFR from a population-based serological survey in one
department of Colombia, Córdoba (Population = 1 785 000), which
was carried out during the aftermath of the first peak of the
pandemic (August–September 2020).
Methods to select participants and characteristics of serological
tests used have been described elsewhere (Mattar et al., 2020).
Briefly, 2447 people, >9 years old, were selected from randomly
selected households from all neighborhoods in 6 cities of the
department. Blood samples were taken after a consent format was
signed, and sera were collected from native individuals from the
Córdoba Department. Sera were tested at the Instituto de Inves-
tigaciones Biológicas del Trópico using INgezim COVID-19 DR test
(Ingenasa, Eurofins Madrid, Spain), a dual recognition enzyme-
linked immunosorbent assay, detecting semi-quantitatively total
SARS-CoV-2 virus N-protein-specific antibodies (immunoglobulin
(Ig)G, IgM, and IgA). The assay has a sensitivity (Se) of 93% and a
specificity (Sp) of 95%. Prevalence data were adjusted by Se and Sp.
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etected COVID-19 cases, and population size were disaggregated
y the age groups shown in Table 1. The number of people infected
as estimated by specific age groups, along with the 95% CIs, by
ultiplying the proportion of seropositive by the population size
f the same group. Then, COVID-19 deaths (confirmed by PCR or
ntigen tests) were divided by the size of the population infected to
btain IFR by age group. CFR by age group was estimated by
ividing deaths by the number of cases detected by the
urveillance system, Table 1.
There were 1618 COVID-19 deaths during the study period for a
FR of 5.6%, IFR of 0.24% (for people aged 10) and mortality rate of
04 per 105. All estimates were lower among young people and
ncreased substantially among the oldest age groups. The lowest
FR value was observed for people aged 10–14 years, 0.001%, and
he highest among people aged 70 years, 1.5%. The overall ratio
FR:IFR was 23, but it was wider among the youngest people: 100
or children <15 years, decreasing to 25 for the age group 20–29
ears and leveling off between 17 and 21.
To the authors’ knowledge, ours is the first report in Colombia
ttempting to estimate IFR from a serological survey. It shows 2
mportant things: first, that CFR overestimates the lethality of
OVID-19 and second, that the bias is differential by age groups. IFR
s lower than CFR for every age group but especially for those under
5 years old. The surveillance system identified 1 in every 22
nfected cases, but only 1 in 100 for children under 15 years old. The
FR obtained in this study raises an issue about the utility of CFR to
ssess the effectiveness of health services. By the time of the
urvey, Córdoba had twice the CFR of the country, 3.1%, but a
izable portion of the difference is explained by surveillance
ensitivity and not by health care effectiveness.
One potential source of error of our study is that serological
ests do not have 100% Se or Sp, so IFR may be overestimated.
owever, we adjusted the prevalence by Se and Sp, and there were
o significant differences between adjusted and unadjusted values.
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old value signify <0.005.
a Expected infections = (seropositivity*population 2020)/100.
b Population under 10 years old was excluded from the serological survey and consequently from these estimates.herefore, these results may guide the discussion about the right
ontrol measures that should be adopted to control future
pidemic waves (Melnick and Ioannidis, 2020).2
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